A study of secondary cutaneous amyloidosis in basal cell carcinoma in Chinese patients: Lack of correlation with bcl-2 or p53 protein expression

Archives of Dermatological Research

Volumn 292, Issue 8, 2000, Pages 379-383

  Wang, W J ^a   Huang, J Y ^a   Wong, C K ^a   Chang, Y T ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Amyloid; Basal cell carcinoma; bcl 2; p53; TUNEL

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; AMYLOIDOSIS; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CAUCASIAN; CHINESE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SKIN BIOPSY;

EID: 0033867361     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030000153     Document Type: Article

References (31)

1. 1. Marks R (1987) Nonmelanotic skin cancer and solar keratoses: the quiet 20th century epidemic. Int J Dermatol 26: 201-205
2. 2. Mahmoud SF (1996) Basal cell carcinoma in Qatar. Int J Dermatol 35: 704-706
3. 3. Weedon D, Shand E (1979) Amyloid in basal cell carcinoma. Br J Dermatol 101: 141-146
4. 4. Looi LM (1983) Localized amyloidosis in basal cell carcinoma - a pathologic study. Cancer 52: 1833-1836
5. 5. Satti MB, Azzopardi JG (1990) Amyloid deposits in basal cell carcinoma of the skin. J Am Acad Dermatol 22: 1082-1087
6. 6. Olsen KE, Westermark P (1994) Amyloid in basal cell carcinoma and seborrheic keratosis. Acta Derm Venereol (Stockh) 74: 273-275
7. 7. Wikonkal NM, Berg RJW, van Hanselen CW, Horkay I, Remenyik E, Begany A, Hunyadi J, van Vloten WA, de Gruijl FR (1997) bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Arch Dermatol 133: 599-602
8. 8. Wong CK (1990) History and modern concepts. Clin Dermatol 8: 1-6
9. 9. Wong CK (1974) Lichen amyloidosus. A relatively common skin disorder in Taiwan. Arch Dermatol 110: 438-440
10. 10. Kirkham N (1997) Tumors and cysts of the epidermis. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr (eds) Lever's histopathology of the skin. Lippincott-Raven, Philadelphia, pp 719-731
11. 11. Maloney ME, Jones DB, Sexton FM (1992) Pigmented basal cell carcinoma: investigation of 70 cases. J Am Acad Dermatol 27: 74-78
12. 12. Kikuchi A, Shimizu H, Nishikawa T (1996) Clinical and histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol 132: 320-324
13. 13. Chang YT, Wong CK, Chow KC, Tsai CH (1999) Apoptosis in primary cutaneous amyloidosis. Br J Dermatol 140: 210-215
14. 14. Murata Y, Kumano K, Sashikata T (1996) Partial spontaneous regression of Bowen's disease. Arch Dermatol 132: 429-432
15. 15. Norris DA (1995) Differential control of cell death in the skin. Arch Dermatol 131: 945-948
16. 16. Raskin CA (1997) Apoptosis and cutaneous biology. J Am Acad Dermatol 36: 855-896
17. 17. Mooney EE, Peris JMR, O'Neill A, Sweeney EC (1995) Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 48: 242-244
18. 18. Hametner R, Lang R, Kaserer C, Koller J, Hintner H (1995) Evaluation of apoptosis in four different types of basal cell carcinoma - a morphometric study. J Invest Dermatol 105: 509
19. 19. Mori O, Hachisuka H, Morita M, Kiyokawa C, Sasai Y (1996) Apoptosis identified with DNA fragmentation in basal cell carcinomas. Arch Dermatol Res 288: 258-261
20. 20. Nakagawa K, Yamamura K, Maeda S, Ichihashi M (1994) bcl-2 expression in epidermal keratinocytic diseases. Cancer 74: 1720-1724
21. 21. Morales-Ducret CRJ, van de Rijn M, LeBrun DP, Smoller BR (1995) bcl-2 expression in primary malignancies of the skin. Arch Dermatol 131: 909-912
22. 22. Verhaegh ME, Sanders CJ, Arends JW, Neumann HA (1995) Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Br J Dermatol 132: 740-744
23. 23. Swanson PE, Fitzpatrick MM, Ritter JH, Glusac EJ, Wick MR (1998) Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol 25: 153-159
24. 24. McGregor JM, Yu CCW, Dublin EA, Levison DA, MacDonald DM (1992) Aberrant expression of p53 tumor-suppressor protein in non-melanoma skin cancer. Br J Dermatol 127: 463-469
25. 25. Campbell C, Quinn AG, Angus B, Rees JL (1993) The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer. Br J Dermatol 129: 235-241
26. 26. Ro YS, Cooper PN, Lee JA, Quinn AG, Harrison D, Lane D, Horne CHW, Rees JL, Angus B (1993) p53 protein expression in benign and malignant skin tumors. Br J Dermatol 128: 237-241
27. 27. Helander SD, Peters MS, Pittelkow MR (1993) Expression of p53 protein in benign and malignant epidermal pathologic conditions. J Am Acad Dermatol 29: 741-748
28. 28. Basset-Séguin N, Molés JP, Mils V, Dereure O, Guilhou JJ (1994) TP53 tumor suppressor gene and skin carcinogenesis. J Invest Dermatol 103: 102S-106S
29. 29. Ro YS (1995) Oncogene interaction in basal cell carcinomas of human skin. J Korean Med Sci 10: 85-92
30. 30. Onodera H, Nakamura S, Sugai T (1996) Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms. Am J Dermatopathol 18: 580-588
31. 31. Barrett TL, Smith KJ, Hodge JJ, Butler R, Hall FW, Skelton HG (1997) Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. J Am Acad Dermatol 37: 430-437